All times are stated in CEST

OPENING PLENARY AND INTRODUCTION TO IPVC (LIVE)

Tuesday, July 21 | 18:00 – 19:10 | Live Sessions Hall

Welcome by the meeting co-chair

Silvia De Sanjose, USA (PATH, Director of Scale-up Project Reproductive Health Global Program)

Welcome by the IPVS President and meeting co-chair

Margaret Stanley, UK (University of Cambridge, Department of Pathology, Emeritus Professor of Epithelial Biology)

Immunology

Rafi Ahmed, USA (Emory Vaccine Center, Director)

IPVC PLENARY SESSION 2 (LIVE)

Wednesday, July 22 | 18:00 – 19:40 | Live Sessions Hall

Global control of Hepatitis B

Alex Vorsters, Belgium (University of Antwerp, Vaccine & Infectious Disease Institute) – a member of Prof. Pierre Van Damme’s team

HPV Pathogenesis in Animal Models

Paul Lambert, USA (Carbone Cancer Center, Director of the McArdle Laboratory for Cancer Research, Virology Program Leader)

Immunotherapy: Progress in the clinic

Cornelis Melief, The Netherlands (ISA Pharmaceuticals, Chief Scientific Officer; Leiden University Medical Center, Emeritus Professor and Head of the Department of Immunohematology and Blood Transfusion)

Live Q&A

All speakers and chairs

IPVC PLENARY SESSION 3 (LIVE)

Thursday, July 23 | 18:00 – 19:40 | Live Sessions Hall

T cell dysfunction and implications for immunotherapy

Andrea Schietinger, USA (Memorial Sloan Kettering Cancer Center, Assistant Professor and Cancer Immunologist)

Laser ART and CRISPR approaches for viral elimination

Howard Gendelman, USA (Durham Research Center, Professor of Internal Medicine and Infectious Diseases)

DNA Methylation and Women’s Cancers

Martin Widschwendter, UK (University College London, Head of the Department of Women’s Cancer)

Live Q&A

All speakers and chairs

IPVC PLENARY SESSION 4 (Pre-recorded)

Friday, July 24 | 11:00 – 12:35 | Hall A

Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer

Corey Casper, USA (Infectious Disease Research Institute, Interim President and Chief Scientific Officer)

Use of Deep Learning into Cervical Cancer Screening

Mark Schiffman, USA (National Cancer Institute, Senior Investigator)

Oral Cancer Therapeutics

Robert Ferris, USA (UPMC Hillman Cancer Center, Director)

IPVC CLOSING PLENARY (LIVE)

Friday, July 24 | 18:00 – 19:30 | Live Sessions Hall

Introduction

Margaret Stanley, UK (University of Cambridge, Department of Pathology, Emeritus Professor of Epithelial Biology)

Immunology HPV vaccines

Denise Galloway, USA (Fred Hutch; Pathogen-Associated Malignancies Integrated Research Center, Scientific Director)

Followed by:

Live Q&A with Denise Galloway

HPV, a personal view (Pre-recorded)

Xavier Bosch, Spain (Catalan Institute of Oncology (ICO), Honorary Consultant to the Cancer Epidemiology Research Program & Director of the e-oncologia at ICO)

Video message from Dr Adhanom Ghebreyesus, Director-General of the World Health Organization (Pre-recorded)

WHO’s Cervical Cancer Elimination Strategy

Princess Nothemba Simelela, Switzerland (Assistant Director-General/Special Adviser to DG, Strategic Programmatic Priorities)

IPVC 2021

Ann Burchell, Canada (Dept of Family and Community Medicine and MAP Centre for Urban Health Solutions, St Michael’s Hospital, Associate Professor)

Closing remarks

Silvia De Sanjose, USA (PATH, Director of Scale-up Project Reproductive Health Global Program)